SeerPharma is proud to be sponsoring the 2026 BridgeTech Symposium, reaffirming our commitment to supporting the next generation of medical technology innovators and advancing quality and regulatory excellence across the MedTech sector.
The BridgeTech Program is a year-long national professional development initiative designed to help researchers, innovators, and entrepreneurs successfully navigate the complex pathway from concept to commercialisation. Administered by the Queensland University of Technology (QUT), the program equips participants with the practical knowledge, industry connections, and commercial insights needed to bring innovative medical device technologies to market.
Throughout the year, participants engage in online learning, expert-led webinars, and industry presentations before coming together for the program's flagship event—the annual BridgeTech Symposium.
Held in Brisbane from 18–21 August 2026, this year's Symposium marks the eighth annual gathering and brings together emerging MedTech companies, researchers, investors, and industry experts. The program features:
In-depth seminars led by industry leaders
Practical case studies exploring real-world commercialisation challenges
Collaborative industry-hosted workshops and networking activities
A Gala Dinner celebrating innovation and achievement across the MedTech sector
For many early-stage companies, commercial success depends not only on developing innovative technology but also on establishing robust quality systems, regulatory strategies, and scalable operational processes from the outset.
For more than 35 years, SeerPharma has partnered with pharmaceutical and medical device organisations throughout the Asia-Pacific region to help them address these critical challenges. Our Medical Device consulting team has supported organisations developing a diverse range of innovative technologies, including implantable medical devices, neurotechnology, in vitro diagnostics, digital health solutions, and advanced diagnostic platforms. By integrating quality, regulatory, and commercial considerations early in the product development lifecycle, we help organisations accelerate market readiness while meeting the expectations of regulators and customers alike.
Drawing on this experience, SeerPharma's Medical Device Manager, Hayley Cameron, will present during Day 1 of the Symposium. Her presentation will examine the regulatory, quality, and commercial considerations that are critical to successfully translating innovative medical technologies into market-ready products. The session will provide practical insights to help emerging MedTech organisations establish strong foundations for sustainable growth and regulatory success.
We look forward to engaging with the outstanding researchers, entrepreneurs, and industry leaders participating in this year's program and contributing to the continued growth of Australia's MedTech ecosystem.
Learn more about the BridgeTech Program
Learn more about SeerPharma's Medical Device consulting services
Supporting leading industry events and sharing practical insights gained through decades of experience is one of the many ways SeerPharma continues to fulfil its mission to “Advance Quality and GMP Best Practices in the APAC Region”.